Point72 Asset Management, L.P.

Holdings History for Arcus Biosciences, Inc. - Common Stock (RCUS)

Symbol: RCUS on NYSE
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 4,332,479 shares
Security Ownership %: 4.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Point72 Asset Management, L.P. ownership in Arcus Biosciences, Inc. Common Stock (RCUS)

14 Nov 2025 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,332,479 shares of Arcus Biosciences, Inc. Common Stock (RCUS). This represents 4.1% ownership of the company. In their previous filing dated 13 May 2025, Point72 Asset Management, L.P. had reported owning 5,831,099 shares, indicating a decrease of +26%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Point72 Asset Management, L.P.	4.1%	-28%	$58,921,714	4,332,479	-1,498,620	-26%	$13.60	13G/A	30 Sep 2025	14 Nov 2025, 16:07
Point72 Asset Management, L.P.	5.5%		$48,398,122	5,831,099			$8.30	13G	12 May 2025	13 May 2025, 17:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.12%	-0.04%	$78,162,400	3,280,000	-1,052,479	-24%	$23.83	Q4 2025
30 Sep 2025	0.13%	-0.05%	$58,921,714	4,332,479	-1,634,185	-27%	$13.60	Q3 2025
30 Jun 2025	0.11%	+0.06%	$48,568,642	5,966,664	+3,099,567	+108%	$8.14	Q2 2025
31 Mar 2025	0.06%	+0.02%	$22,506,712	2,867,097	+870,818	+44%	$7.85	Q1 2025
31 Dec 2024	0.08%	-0.02%	$29,724,594	1,996,279	-440,794	-18%	$14.89	Q4 2024
30 Sep 2024	0.13%	+0.03%	$37,262,846	2,437,073	+603,222	+33%	$15.29	Q3 2024
30 Jun 2024	0.09%	-0%	$27,929,551	1,833,851	-81,081	-4.2%	$15.23	Q2 2024
31 Mar 2024	0.1%	+0.06%	$36,153,916	1,914,932	+1,146,182	+149%	$18.88	Q1 2024
31 Dec 2023	0.04%	+0.04%	$14,683,125	768,750	+764,293	+17148%	$19.10	Q4 2023
30 Sep 2023	0%	-0.04%	$80,003	4,457	-705,184	-99%	$17.95	Q3 2023
30 Jun 2023	0.05%	+0.05%	$14,412,809	709,641	+709,641	NEW	$20.31	Q2 2023
31 Mar 2023		-0.03%	$0	0	-425,301	-100%	$20.78	Q1 2023
31 Dec 2022	0.03%	+0.03%	$8,795,225	425,301	+367,467	+635%	$20.68	Q4 2022
30 Sep 2022	0.01%	+0.01%	$1,513,000	57,834	+57,834	NEW	$26.16	Q3 2022
30 Jun 2021		-0.01%	$0	0	-62,926	-100%	$20.78	Q2 2021
31 Mar 2021	0.01%	+0.01%	$1,767,000	62,926	+62,926	NEW	$28.08	Q1 2021
31 Dec 2020		-0.02%	$0	0	-194,001	-100%	$20.78	Q4 2020
30 Sep 2020	0.02%	+0.02%	$3,325,000	194,001	+194,001	NEW	$17.14	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.